Financial Performance - The company reported revenue of SGD 23,578,000 for the six months ended September 30, 2020, an increase of 3.35% compared to SGD 22,812,000 for the same period in 2019[4]. - Gross profit for the same period was SGD 5,564,000, down from SGD 6,156,000 in 2019, representing a decrease of 9.6%[4]. - Other income increased significantly to SGD 1,191,000 from SGD 295,000, marking a growth of 303.39%[4]. - The company incurred a loss of SGD 104,000 from other gains/losses, compared to a gain of SGD 312,000 in the previous year[4]. - The total comprehensive income for the period attributable to owners of the company was SGD 2,698,000, compared to SGD 2,182,000 in the same period last year, reflecting an increase of 23.6%[4]. - Basic and diluted earnings per share were SGD 0.38, down from SGD 0.49 in the previous year, indicating a decrease of 22.45%[4]. - The company reported a net loss from biological asset fair value changes of SGD 14,222,000, compared to a loss of SGD 590,000 in the previous year[154][158]. - The company recorded a pre-tax profit of SGD 2,140,000 for the six months ended September 30, 2020, compared to SGD 2,518,000 in the previous year, showing a decrease of approximately 15%[158]. - The company reported a profit attributable to equity holders of SGD 1,896,000 for the six months ended September 30, 2020, down from SGD 2,182,000 in the same period of 2019, representing a decrease of approximately 13.1%[176]. Assets and Liabilities - The company’s total assets as of September 30, 2020, were reported at SGD 50,000,000, compared to SGD 48,000,000 as of March 31, 2020, showing an increase of 4.17%[4]. - Total assets increased to SGD 51,251,000 from SGD 43,540,000, representing a growth of approximately 17.4%[75]. - Current liabilities rose to SGD 12,570,000 from SGD 9,795,000, an increase of about 28.7%[77]. - Total liabilities increased to SGD 22,574,000 from SGD 16,759,000, marking a rise of about 34.8%[77]. - Net assets increased to SGD 28,677,000 from SGD 26,781,000, reflecting a growth of approximately 7.1%[77]. - The company’s total equity increased to SGD 28,677,000 from SGD 26,781,000, representing a growth of about 7.1%[77]. Cash Flow and Expenses - Cash and cash equivalents increased significantly to SGD 13,748,000 from SGD 9,011,000, a rise of about 52.5%[119]. - Operating cash flow for the six months ended September 30 was SGD 7,846,000, compared to SGD 3,136,000 in the previous period, indicating a substantial increase of approximately 150.5%[126]. - Employee benefits expenses increased to SGD 1,973,000 from SGD 1,547,000, reflecting a year-over-year increase of approximately 27.6%[154][158]. - The total operating expenses for the six months ended September 30, 2020, amounted to SGD 26,186,000, compared to SGD 22,867,000 in the same period of 2019, representing an increase of approximately 14.4%[168]. - The company incurred finance costs of SGD 164,000 for the six months ended September 30, 2020, down from SGD 222,000 in the previous year[167]. Inventory and Production - The company’s inventory increased to SGD 2,111,000 from SGD 1,641,000, reflecting a growth of approximately 28.6%[75]. - The total inventory purchased during the period was SGD 398,000, compared to SGD 13,023,000 in the previous year, indicating a significant reduction in inventory purchases[154][158]. - The company harvested 68,706,822 eggs during the six months ended September 30, 2020, compared to 66,698,054 eggs in the same period of 2019, representing an increase of approximately 3%[185]. Market and Future Plans - The company plans to continue expanding its market presence and invest in new product development to drive future growth[4]. - The company has not disclosed any significant new product developments or market expansions during the reporting period[159]. Shareholder Information - The weighted average number of ordinary shares issued increased to 500,000,000 shares in 2020 from 445,548,000 shares in 2019, reflecting a significant increase in share issuance[176]. - The company did not declare any interim dividend for the six months ended September 30, 2020, consistent with the previous year[177]. Biological Assets - The fair value of biological assets decreased to SGD 3,281,000 as of September 30, 2020, from SGD 4,270,000 as of the same date in 2019, a decline of about 23.2%[180]. - The company’s biological assets include 2,539,000 mature hens and 742,000 immature hens as of September 30, 2020, compared to 3,736,000 mature hens and 534,000 immature hens as of March 31, 2020, indicating a reduction in total biological assets[180]. Other Information - The board confirmed that all information provided in the announcement is accurate and complete, with no misleading or fraudulent elements[2]. - The company will publish its interim report on its website and the GEM website for at least seven days from the announcement date[3].
永续农业(08609) - 2021 - 中期财报